Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
European Urology|April 15, 2000
Where are the limits of elective nephron- sparing surgery in renal cell carcinoma?A Schlichter, H Wunderlich, K Junker, et al.Der Urologe. Ausg. A|July 17, 1999
[Increased incidence of renal cell carcinoma in central Europe. Does diagnostic increase reflect a true increase in incidence?]H Wunderlich, S Schumann, V Janitzky, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|November 28, 2008
Direct zincation of functionalized aromatics and heterocycles by using a magnesium base in the presence of ZnCl2Zhibing Dong, Giuliano C Clososki, Stefan H Wunderlich, et al.Die Pharmazie|December 1, 1985
[New derivatives of 10,11-dihydro-5H-dibenz[b,f]azepine with antiarrhythmic action]H Wunderlich, A Stark, E Carstens, et al.Urologia Internationalis|April 27, 2000
The correlation of p53 protein overexpression and p53 antibodies in serum of patients with transitional cell carcinoma of the urinary bladderH Wunderlich, W Hindermann, M Hüller, et al.Chemistryopen|July 23, 2014
Magnetic resonance access to transiently formed protein complexesTomáš Sára, Thomas C Schwarz, Dennis Kurzbach, et al.Urologia Internationalis|March 20, 2010
Downsizing a tumor thrombus of advanced renal cell carcinoma with neoadjuvant systemic therapy and resulting histopathological effectsN Kroeger, M Gajda, J Zanow, et al.European Urology|September 23, 1998
Increase of renal cell carcinoma incidence in central EuropeH Wunderlich, S Schumann, V Jantitzky, et al.Journal of Medicinal Chemistry|December 10, 2016
Measurement of Ligand-Target Residence Times by 1H Relaxation Dispersion NMR SpectroscopyThomas Moschen, Sarina Grutsch, Michael A Juen, et al.European Urology|March 24, 1999
Real indications for adrenalectomy in renal cell carcinomaH Wunderlich, A Schlichter, O Reichelt, et al.Pageof 7